Streetbeat News

Stock Prices

YUM

Yum Brands Inc. (NYSE:YUM) has seen its shares fall by 1.18% over the past three months. The company's financial statement as of May 9, 2023, reveals a total debt of $11.75 billion, adjusted for $349.00 million in cash-equivalents, resulting in a net debt of $11.40 billion. The debt-ratio, considering Yum Brands's $5.75 billion in total assets, is at 2.04, indicating a large portion of debt is funded by assets.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:45 pm

GBNH

Greenbrook TMS Inc. (NASDAQ:GBNH) has entered into an equity purchase agreement with Alumni Capital LP. The agreement provides equity line financing for sales of up to approximately $4.4 million of common shares in the share capital of the company. The agreement expires on December 31, 2023, or when the aggregate offering amount of offered shares meets the maximum commitment amount. The company intends to use the proceeds for general corporate and working capital purposes.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 8:43 pm

LESL

Leslie's Inc (NASDAQ:LESL) shares dropped nearly 20% in after-hours trading following the release of preliminary Q3 results and the announcement of a CFO transition. The company's Q3 revenue is expected to be $611 million, significantly lower than the estimated $703.74 million. Adjusted earnings are anticipated to be between 39 cents and 41 cents per share, compared to estimates of 69 cents per share. The company also lowered its full-year 2023 revenue outlook. CFO Steve Weddell is stepping down and will be replaced by Scott Bowman.

Portfolio Pulse from Adam Eckert

July 13, 2023 | 8:31 pm

THRX

Trading of Theseus Pharmaceuticals shares is set to resume at 4:35 p.m. ET.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:31 pm

HMC

Honda Motor Co's (NYSE:HMC) short percent of float has fallen 9.09% since its last report, with 1.67 million shares sold short, which is 0.1% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards Honda. Compared to its peers, Honda has less short interest as a percentage of float, with an average of 10.79%.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:30 pm

FANG

Over the past 10 years, Diamondback Energy (NASDAQ:FANG) has outperformed the market by 3.64% on an annualized basis, producing an average annual return of 13.98%. If an investor had bought $100 of FANG stock 10 years ago, it would be worth $369.69 today.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:30 pm

SNOW

Snowflake's (NYSE:SNOW) short percent of float has fallen 15.33% since its last report, with 11.63 million shares sold short, which is 3.7% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards Snowflake. Compared to its peers, Snowflake has less short interest as a percentage of float, with an average of 6.24%.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:30 pm

LULU

Lululemon Athletica's (NYSE:LULU) short percent of float has fallen 7.64% since its last report, with 2.63 million shares sold short, which is 2.54% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. Lululemon's short interest is less than the average of its peer group, which stands at 7.40%.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:30 pm

MTD

Mettler-Toledo Intl (NYSE:MTD) has outperformed the market over the past 15 years, producing an average annual return of 18.96%. If an investor had bought $1000 of MTD stock 15 years ago, it would be worth $13,860.84 today.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:30 pm

ATOS

Atossa Therapeutics, Inc. (NASDAQ:ATOS) has regained compliance with the Nasdaq minimum closing bid price requirement for continued listing on The Nasdaq Capital Market. The company was previously not in compliance due to its common stock failing to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The company has made significant progress with its (Z)-endoxifen development program and has over $100 million cash with no debt.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:18 pm